{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:48:40Z","timestamp":1792201720368,"version":"4.4.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T00:00:00Z","timestamp":1505865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T00:00:00Z","timestamp":1505865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hypertrophic cardiomyopathy (HCM) is a clinically and genetically heterogeneous disorder but data on survival rates are still conflicting and have not so far been quantitatively reviewed. The aim of this study is to conduct a meta-analysis of cohort studies to assess pooled survival rates and prognostic factors for survival in patients with HCM. Nineteen studies were included representing 12,146 HCM patients. The pooled 1-, 3-, 5- and 10-year survival rates were 98.0%, 94.3%, 82.2% and 75.0%, respectively. Among patients with HCM, age, NYHA functional class, family history of sudden death (FHSD), syncope, atrial fibrillation, non-sustained ventricular tachycardia (nsVT), maximum left ventricular wall thickness and obstruction were significant prognostic factors for cardiovascular death. For sudden cardiac death, FHSD, nsVT, and obstruction showed significant predictive values. Moreover, estimation of population attributable risk (PAR) suggested that nsVT was the strongest predictor for cardiovascular death (13.02%, 95% CI 3.60\u201325.91%), while left ventricular outflow tract obstruction\/mid-ventricular obstruction (LVO\/MVO) was the strongest predictor for all-cause death and sudden cardiac death (10.09%, 95% CI 4.72\u201320.42% and 16.44%, 95% CI 7.45\u201331.55%, respectively). These risk factors may thus be useful for identifying HCM patients who might benefit from early diagnosis and therapeutic interventions.<\/jats:p>","DOI":"10.1038\/s41598-017-12289-4","type":"journal-article","created":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T10:27:39Z","timestamp":1505384859000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Survival and prognostic factors in hypertrophic cardiomyopathy: a meta-analysis"],"prefix":"10.1038","volume":"7","author":[{"given":"Qun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diandian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan E.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger A.","family":"Johns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,20]]},"reference":[{"key":"12289_CR1","first-page":"435","volume":"92","author":"AJ Marian","year":"2001","unstructured":"Marian, A. J., Salek, L. & Lutucuta, S. Molecular genetics and pathogenesis of hypertrophic cardiomyopathy. Minerva Med. \n                           92, 435\u2013451 (2001).","journal-title":"Minerva Med."},{"key":"12289_CR2","first-page":"193","volume":"287","author":"T Sasaki","year":"1996","unstructured":"Sasaki, T., Nakao, S. & Tanaka, H. Hypertrophic cardiomyopathy. Ryoikibetsu Shokogun Shirizu \n                           287, 193\u2013198 (1996).","journal-title":"Ryoikibetsu Shokogun Shirizu"},{"key":"12289_CR3","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","volume":"65","author":"C Semsarian","year":"2015","unstructured":"Semsarian, C., Ingles, J., Maron, M. S. & Maron, B. J. New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy. J. Am. Coll. Cardiol. \n                           65, 1249\u20131254 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"12289_CR4","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1253\/circj.CJ-12-1561","volume":"77","author":"GK Efthimiadis","year":"2013","unstructured":"Efthimiadis, G. K., Pagourelias, E. D. & Parcharidou, D. Clinical Characteristics and Natural History of Hypertrophic Cardiomyopathy With Midventricular Obstruction. Circ. J. \n                           77, 2366\u20132374 (2013).","journal-title":"Circ. J."},{"key":"12289_CR5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.jacc.2004.11.043","volume":"45","author":"AS Adabag","year":"2005","unstructured":"Adabag, A. S., Casey, S. A., Kuskowski, M. A., Zenovich, A. G. & Maron, B. J. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. \n                           45, 697\u2013704 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"12289_CR6","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.ahj.2004.09.049","volume":"149","author":"E Arteaga","year":"2005","unstructured":"Arteaga, E., Ianni, B. M., Fernandes, F. & Mady, C. Benign outcome in a long-term follow-up of patients with hypertrophic cardiomyopathy in Brazil. Am. Heart J. \n                           149, 1099\u20131105 (2005).","journal-title":"Am. Heart J."},{"key":"12289_CR7","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1093\/eurheartj\/ehq308","volume":"31","author":"PP Dimitrow","year":"2010","unstructured":"Dimitrow, P. P., Chojnowska, L. & Rudzinski, T. Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up. Eur. Heart J. \n                           31, 3084\u20133093 (2010).","journal-title":"Eur. Heart J."},{"key":"12289_CR8","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu199","volume":"35","author":"PM Elliott","year":"2014","unstructured":"Elliott, P. M., Anastasakis, A. & Borger, M. A. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur. Heart J. \n                           35, 2733\u20132779 (2014).","journal-title":"Eur. Heart J."},{"key":"12289_CR9","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.amjcard.2013.02.040","volume":"111","author":"KW Klarich","year":"2013","unstructured":"Klarich, K. W., Attenhofer, J. C. H. & Binder, J. Risk of Death in Long-Term Follow-Up of Patients With Apical Hypertrophic Cardiomyopathy. Am. J. Cardiol. \n                           111, 1784\u20131791 (2013).","journal-title":"Am. J. Cardiol."},{"key":"12289_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ahj.2015.05.013","volume":"170","author":"CM Kramer","year":"2015","unstructured":"Kramer, C. M., Appelbaum, E. & Desai, M. Y. Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy. Am. Heart J. \n                           170, 223\u2013230 (2015).","journal-title":"Am. Heart J."},{"key":"12289_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.echo.2008.11.001","volume":"22","author":"MA Losi","year":"2009","unstructured":"Losi, M. A., Betocchi, S. & Barbati, G. Prognostic Significance of Left Atrial Volume Dilatation in Patients with Hypertrophic Cardiomyopathy. J. Am. Soc. Echocardiogr. \n                           22, 76\u201381 (2009).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"12289_CR12","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s00380-008-1131-0","volume":"24","author":"A Nemes","year":"2009","unstructured":"Nemes, A. et al. Long-term prognostic value of coronary flow velocity reserve in patients with hypertrophic cardiomyopathy: 9-year follow-up results from SZEGED study. Heart Vessels \n                           24, 352\u2013356 (2009).","journal-title":"Heart Vessels"},{"key":"12289_CR13","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1161\/hc4601.097997","volume":"104","author":"I Olivotto","year":"2001","unstructured":"Olivotto, I. et al. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation \n                           104, 2517\u20132524 (2001).","journal-title":"Circulation"},{"key":"12289_CR14","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/S0735-1097(99)00094-7","volume":"33","author":"I Olivotto","year":"2044","unstructured":"Olivotto, I. et al. Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. \n                           33, 2044\u20132051 (2044).","journal-title":"J. Am. Coll. Cardiol."},{"key":"12289_CR15","doi-asserted-by":"crossref","unstructured":"Shin, D. G., Son, J., Park, J. Y., Choi, J. W. & Ryu, S. K. Impact of Coronary Artery Anatomy on Clinical Course and Prognosis in Apical Hypertrophic Cardiomyopathy: Analysis of Coronary Angiography and Computed Tomography. 38\u201343 (2015).","DOI":"10.4070\/kcj.2015.45.1.38"},{"key":"12289_CR16","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.157656","volume":"128","author":"X-L Zhou","year":"2015","unstructured":"Zhou, X.-L. et al. Clinical Characteristics and Prognosis of End-stage Hypertrophic Cardiomyopathy. Chin. Med. J. (Engl). \n                           128, 1483 (2015).","journal-title":"Chin. Med. J. (Engl)."},{"key":"12289_CR17","doi-asserted-by":"crossref","unstructured":"Kawasaki, T. et al. Prognostic Value of Heart Rate Variability in Patients With Hypertrophic. J. Electrocardiol. 36 (2003).","DOI":"10.1016\/j.jelectrocard.2003.08.005"},{"key":"12289_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0140-6736(12)60397-3","volume":"381","author":"BJ Maron","year":"2013","unstructured":"Maron, B. J. & Maron, M. S. Hypertrophic cardiomyopathy. Lancet \n                           381, 242\u2013255 (2013).","journal-title":"Lancet"},{"key":"12289_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0735-1097(88)90181-7","volume":"11","author":"WJ McKenna","year":"1988","unstructured":"McKenna, W. J., Franklin, R. C., Nihoyannopoulos, P., Robinson, K. C. & Deanfield, J. E. Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. \n                           11, 147\u201353 (1988).","journal-title":"J. Am. Coll. Cardiol."},{"key":"12289_CR20","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1136\/hrt.2006.095232","volume":"93","author":"A Nasermoaddeli","year":"2007","unstructured":"Nasermoaddeli, A. et al. Prognosis and prognostic factors in patients with hypertrophic cardiomyopathy in Japan: results from a nationwide study. Heart \n                           93, 711\u2013715 (2007).","journal-title":"Heart"},{"key":"12289_CR21","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S0140-6736(00)04005-8","volume":"357","author":"PM Elliott","year":"2001","unstructured":"Elliott, P. M., Gimeno Blanes, J. R., Mahon, N. G., Poloniecki, J. D. & McKenna, W. J. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet \n                           357, 420\u20134 (2001).","journal-title":"Lancet"},{"key":"12289_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1542-474X.2001.tb00110.x","volume":"6","author":"G Yi","year":"2001","unstructured":"Yi, G. et al. Is QT dispersion associated with sudden cardiac death in patients with hypertrophic cardiomyopathy? Ann. Noninvasive Electrocardiol. \n                           6, 209\u201315 (2001).","journal-title":"Ann. Noninvasive Electrocardiol."},{"key":"12289_CR23","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S0735-1097(03)00827-1","volume":"42","author":"L Monserrat","year":"2003","unstructured":"Monserrat, L. et al. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. \n                           42, 873\u2013879 (2003).","journal-title":"J. Am. Coll. Cardiol."},{"key":"12289_CR24","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.nuclcard.2004.05.008","volume":"11","author":"G Romerofarina","year":"2004","unstructured":"Romerofarina, G. et al. Do myocardial perfusion SPECT and radionuclide angiography studies in adult patients with hypertrophic cardiomyopathy have prognostic implications? J. Nucl. Cardiol. \n                           11, 578\u2013586 (2004).","journal-title":"J. Nucl. Cardiol."},{"key":"12289_CR25","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.jacc.2005.04.062","volume":"46","author":"E Biagini","year":"2005","unstructured":"Biagini, E. et al. Dilated-Hypokinetic Evolution of Hypertrophic Cardiomyopathy. J. Am. Coll. Cardiol. \n                           46, 1543\u20131550 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"12289_CR26","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.amjcard.2006.05.013","volume":"98","author":"S Nistri","year":"2006","unstructured":"Nistri, S. et al. Prognostic Significance of Left Atrial Size in Patients With Hypertrophic Cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy). Am. J. Cardiol. \n                           98, 960\u2013965 (2006).","journal-title":"Am. J. Cardiol."},{"key":"12289_CR27","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1093\/eurheartj\/ehp327","volume":"30","author":"JR Gimeno","year":"2009","unstructured":"Gimeno, J. R. et al. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy. Eur. Heart J. \n                           30, 2599\u20132605 (2009).","journal-title":"Eur. Heart J."},{"key":"12289_CR28","first-page":"264","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher, D., Liberati, A., Tetzlaff, J. & Altman, D. G. Academia and Clinic Annals of Internal Medicine Preferred Reporting Items for Systematic Reviews and Meta-Analyses: Annu. Intern. Med. \n                           151, 264\u2013269 (2009).","journal-title":"Intern. Med."},{"key":"12289_CR29","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1161\/CIRCULATIONAHA.108.798314","volume":"119","author":"P Spirito","year":"2009","unstructured":"Spirito, P. et al. Syncope and Risk of Sudden Death in Hypertrophic Cardiomyopathy. Circulation \n                           119, 1703\u20131710 (2009).","journal-title":"Circulation"},{"key":"12289_CR30","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.echo.2009.09.016","volume":"22","author":"W-I Yang","year":"2009","unstructured":"Yang, W.-I. et al. Left Atrial Volume Index: A Predictor of Adverse Outcome in Patients With Hypertrophic Cardiomyopathy. J. Am. Soc. Echocardiogr. \n                           22, 1338\u20131343 (2009).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"12289_CR31","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jacc.2010.05.007","volume":"56","author":"O Bruder","year":"2010","unstructured":"Bruder, O. et al. Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy. J. Am. Coll. Cardiol. \n                           56, 875\u2013887 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"12289_CR32","doi-asserted-by":"publisher","first-page":"810","DOI":"10.2459\/JCM.0b013e328356a231","volume":"13","author":"G Finocchiaro","year":"2012","unstructured":"Finocchiaro, G. et al. Prognostic role of clinical presentation in symptomatic patients with hypertrophic cardiomyopathy. J. Cardiovasc. Med. \n                           13, 810\u2013818 (2012).","journal-title":"J. Cardiovasc. Med."},{"key":"12289_CR33","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1007\/s10554-011-9994-z","volume":"28","author":"S Kaimoto","year":"2012","unstructured":"Kaimoto, S. et al. Myocardial perfusion abnormality in the area of ventricular septum-free wall junction and cardiovascular events in nonobstructive hypertrophic cardiomyopathy. Int. J. Cardiovasc. Imaging \n                           28, 1829\u20131839 (2012).","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"12289_CR34","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/ejhf.144","volume":"16","author":"J Wang","year":"2014","unstructured":"Wang, J. et al. Malignant effects of multiple rare variants in sarcomere genes on the prognosis of patients with hypertrophic cardiomyopathy. Eur. J. Heart Fail. \n                           16, 950\u20137 (2014).","journal-title":"Eur. J. Heart Fail."},{"key":"12289_CR35","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jacc.2005.04.043","volume":"46","author":"I Olivotto","year":"2005","unstructured":"Olivotto, I. et al. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. \n                           46, 480\u2013487 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"12289_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0002-9149(87)90972-6","volume":"60","author":"RJ Gibbons","year":"1987","unstructured":"Gibbons, R. J. et al. Anatomic and functional significance of a hypotensive response during supine exercise radionuclide ventriculography. Am. J. Cardiol. \n                           60, 1\u20134 (1987).","journal-title":"Am. J. Cardiol."},{"key":"12289_CR37","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1067\/mhj.2001.115437","volume":"141","author":"BW Karlson","year":"2001","unstructured":"Karlson, B. W., Sjolin, M., Lindqvist, J., Caidahl, K. & Herlitz, J. Ten-year mortality rate in relation to observations at a bicycle exercise test in patients with a suspected or confirmed ischemic event but no or only minor myocardial damage: influence of subsequent revascularization. Am. Heart J. \n                           141, 977\u2013984 (2001).","journal-title":"Am. Heart J."},{"key":"12289_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.atherosclerosis.2014.08.029","volume":"237","author":"Pa Barlow","year":"2014","unstructured":"Barlow, Pa, Otahal, P., Schultz, M. G., Shing, C. M. & Sharman, J. E. Low exercise blood pressure and risk of cardiovascular events and all-cause mortality: Systematic review and meta-analysis. Atherosclerosis \n                           237, 13\u201322 (2014).","journal-title":"Atherosclerosis"},{"key":"12289_CR39","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1093\/eurheartj\/ehl041","volume":"27","author":"J Shah","year":"2006","unstructured":"Shah, J. et al. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J \n                           27, 1933\u20131941 (2006).","journal-title":"Eur Heart J"},{"key":"12289_CR40","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.hfc.2010.05.004","volume":"6","author":"SD Colan","year":"2010","unstructured":"Colan, S. D. Hypertrophic cardiomyopathy in childhood. [{Review}]. Heart Fail. Clin. \n                           6, 433\u2013444 (2010).","journal-title":"Heart Fail. Clin."},{"key":"12289_CR41","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0735-1097(00)01003-2","volume":"36","author":"PM Elliott","year":"2000","unstructured":"Elliott, P. M. et al. Sudden Death in Hypertrophic Cardiomyopathy: Identification of High Risk Patients. JACC \n                           36, 2212\u20132218 (2000).","journal-title":"JACC"},{"key":"12289_CR42","first-page":"1778","volume":"15","author":"S Paolo","year":"2000","unstructured":"Paolo, S. et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med \n                           15, 1778\u20131785 (2000).","journal-title":"N Engl J Med"},{"key":"12289_CR43","first-page":"3229","volume":"26","author":"S Natarajan","year":"2007","unstructured":"Natarajan, S., Lipsitz, S. R. & Rimm, E. A simple method of determining confidence intervals for population attributable risk from complex surveys. Statist. Med. \n                           26, 3229\u20133239 (2007).","journal-title":"Med."},{"key":"12289_CR44","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/ptj\/89.9.873","volume":"89","author":"D Moher","year":"2009","unstructured":"Moher, D., Liberati, A. & Grp, P. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (Reprinted from Annals of Internal Medicine). Phys. Ther. \n                           89, 873\u2013880 (2009).","journal-title":"Phys. Ther."},{"key":"12289_CR45","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins, J. P., Thompson, S. G. & Deeks, J. J. Measuring inconsistency in meta-analyses. BMJ. \n                           327, 557\u2013560 (2003).","journal-title":"BMJ."},{"key":"12289_CR46","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","volume":"45","author":"R DerSimonian","year":"2015","unstructured":"DerSimonian, R. & Laird, N. Meta-Analysis in Clinical Trials Revisited. Contemp. Clin. Trials \n                           45, 139\u2013145 (2015).","journal-title":"Contemp. Clin. Trials"},{"key":"12289_CR47","first-page":"1","volume":"1","author":"J Ferguson","year":"2016","unstructured":"Ferguson, J., Alvarez-iglesias, A. & Donnell, M. O. Estimating average attributable fractions with confidence intervals for cohort and case \u2013 control studies. SMMR \n                           1, 1\u201312 (2016).","journal-title":"SMMR"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12289-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12289-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12289-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T11:16:45Z","timestamp":1671794205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12289-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,20]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["12289"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-12289-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,20]]},"assertion":[{"value":"18 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11957"}}